Cargando…

Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization

OBJECTIVE: CXCL14 (C-X-C motif chemokine ligand-14) is a chemokine released by active brown fat, showing protective effects against insulin resistance in experimental models. Polycystic ovary syndrome (PCOS) in adolescent girls is usually related to hepato-visceral fat excess and insulin resistance,...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Beltran, Cristina, Cereijo, Ruben, Quesada-López, Tania, Malpique, Rita, López-Bermejo, Abel, de Zegher, Francis, Ibáñez, Lourdes, Villarroya, Francesc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206903/ https://www.ncbi.nlm.nih.gov/pubmed/32107266 http://dx.doi.org/10.1136/bmjdrc-2019-001035

Ejemplares similares

MON-029 Polycystic Ovary Syndrome (PCOS) in Adolescent Girls:Toward a Simple On-Treatment Predictor of Post-Treatment Ovulation Rate
por: Ibanez, Lourdes, et al.
Publicado: (2020)

Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome
por: Ibáñez, Lourdes, et al.
Publicado: (2020)

Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome
por: Díaz, Marta, et al.
Publicado: (2018)

OR25-3 Toward a Circulating Marker of Hepato-Visceral Fat Excess: S100A4 in Adolescent Girls with Polycystic Ovary Syndrome
por: Ibanez, Lourdes, et al.
Publicado: (2019)

FRI426 Raised Thyroid Stimulating Hormone In Girls With Polycystic Ovary SyndromeEffects Of Randomized Interventions
por: Ibanez, Lourdes, et al.
Publicado: (2023)

The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat
por: de Zegher, Francis, et al.
Publicado: (2021)

Author Correction: The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat
por: de Zegher, Francis, et al.
Publicado: (2021)

Bone Morphogenetic Protein-8B Levels at Birth and in the First Year of Life: Relation to Metabolic-Endocrine Variables and Brown Adipose Tissue Activity
por: Garcia-Beltran, Cristina, et al.
Publicado: (2022)

Meteorin-like levels are associated with active brown adipose tissue in early infancy
por: Garcia-Beltran, Cristina, et al.
Publicado: (2023)

Circulating exosomes decrease in size and increase in number between birth and age 7: relations to fetal growth and liver fat
por: Díaz, Marta, et al.
Publicado: (2023)

Body Composition and Circulating High-Molecular-Weight Adiponectin and IGF-I in Infants Born Small for Gestational Age : Breast- Versus Formula-Feeding
por: de Zegher, Francis, et al.
Publicado: (2012)

Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol
por: Bassols, Judit, et al.
Publicado: (2023)

A Single Nucleotide Polymorphism in STK11 Influences Insulin Sensitivity and Metformin Efficacy in Hyperinsulinemic Girls With Androgen Excess
por: López-Bermejo, Abel, et al.
Publicado: (2010)

Correction: Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol
por: Bassols, Judit, et al.
Publicado: (2023)

SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial
por: Garcia-Beltran, Cristina, et al.
Publicado: (2023)

Nerve Growth Factor Levels in Term Human Infants: Relationship to Prenatal Growth and Early Postnatal Feeding
por: Sánchez-Infantes, David, et al.
Publicado: (2018)

Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome
por: Cao, Shunshun, et al.
Publicado: (2021)

Secretory Proteome of Brown Adipocytes in Response to cAMP-Mediated Thermogenic Activation
por: Villarroya, Joan, et al.
Publicado: (2019)

Differential DNA methylation profile in infants born small-for-gestational-age: association with markers of adiposity and insulin resistance from birth to age 24 months
por: Diaz, Marta, et al.
Publicado: (2020)

Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome
por: Tan, Bee K., et al.
Publicado: (2010)

ODP426 SPIOMET4HEALTH: a 4-Arm Trial to Test the Effects of Lifestyle Intervention plus either Placebo, or Pioglitazone (PIO), or Spironolactone-Pioglitazone (SPIO), or Spironolactone-Pioglitazone-Metformin (SPIOMET) in Adolescent Girls and Young Women with PCOS
por: Ibanez, Lourdes, et al.
Publicado: (2022)

The kallikrein–kinin pathway as a mechanism for auto-control of brown adipose tissue activity
por: Peyrou, Marion, et al.
Publicado: (2020)

On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls
por: de Zegher, Francis, et al.
Publicado: (2021)

Frequency of Subclinical Hypothyroidism in Women With Polycystic Ovary Syndrome
por: Raj, Deepak, et al.
Publicado: (2021)

Type 2 Diabetes Mellitus in Patients With Polycystic Ovary Syndrome
por: Agrawal, Anjali, et al.
Publicado: (2023)

Higher levels of serum α-Klotho are longitudinally associated with less central obesity in girls experiencing weight gain
por: Carreras-Badosa, Gemma, et al.
Publicado: (2023)

Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
por: Hutchison, Samantha K., et al.
Publicado: (2008)

Polycystic Ovary Syndrome Among Female Adolescents With Congenital Adrenal Hyperplasia
por: Abdelhamed, Marwa H, et al.
Publicado: (2021)

Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association
por: Shetty, Chaitra, et al.
Publicado: (2023)

Predictive factors of polycystic ovary syndrome in girls with precocious pubarche
por: Guarnotta, Valentina, et al.
Publicado: (2021)

The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes
por: Quesada-López, Tania, et al.
Publicado: (2016)

Abundance of Circulating Preadipocyte Factor 1 in Early Life
por: de Zegher, Francis, et al.
Publicado: (2012)

New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome
por: Saleem, Fatima, et al.
Publicado: (2017)

Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review
por: Peddemul, Aishwarya, et al.
Publicado: (2022)

Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
por: Layacha, Sakshi Y, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls
por: Witchel, Selma Feldman, et al.
Publicado: (2019)

Why are Women With Polycystic Ovary Syndrome at Increased Risk of Depression? Exploring the Etiological Maze
por: Gnawali, Anupa, et al.
Publicado: (2021)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: A Literature Review With a Focus on Diagnosis, Pathophysiology, and Management
por: Waghmare, Shrutika V, et al.
Publicado: (2023)

Persisting benefits 12–18 months after discontinuation of pubertal metformin therapy in low birthweight girls
por: Ong, Ken, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_rrvgmqitpihn3h84fdvcqpk5qb